mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.2 |
2e-05 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |